Hak Chul Jang Selected Research

Coronary Artery Bypass (Coronary Artery Bypass Surgery)

2/2016	Lower uncarboxylated osteocalcin and higher sclerostin levels are significantly associated with coronary artery disease.
6/2009	Subclinical hypothyroidism might increase the risk of transient atrial fibrillation after coronary artery bypass grafting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hak Chul Jang Research Topics

Disease

54	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2006
33	Insulin Resistance 06/2022 - 11/2006
13	Atherosclerosis 12/2021 - 01/2011
12	Obesity 01/2022 - 01/2006
12	Body Weight (Weight, Body) 01/2022 - 01/2006
8	Coronary Stenosis (Coronary Artery Stenosis) 01/2020 - 07/2009
7	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2019
7	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 11/2014
7	Glucose Intolerance 01/2021 - 02/2011
7	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 05/2011
6	Hyperglycemia 01/2022 - 06/2008
6	Pathologic Constriction (Stenosis) 01/2020 - 07/2009
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 06/2011
6	Hypertension (High Blood Pressure) 09/2017 - 01/2011
5	Hypothyroidism 01/2020 - 06/2009
5	Prediabetic State (Prediabetes) 01/2019 - 11/2014
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 02/2016
5	Dyslipidemias (Dyslipidemia) 01/2018 - 01/2013
4	Inflammation (Inflammations) 06/2022 - 08/2012
4	Sarcopenia 01/2022 - 01/2019
4	Diabetes Mellitus 01/2021 - 01/2011
3	Frailty 01/2022 - 01/2019
3	Non-alcoholic Fatty Liver Disease 12/2021 - 10/2021
3	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 05/2009
3	Hyperthyroidism 01/2020 - 10/2015
3	Abdominal Obesity 06/2019 - 01/2013
3	Thyrotoxicosis 07/2018 - 02/2018
3	Weight Loss (Weight Reduction) 11/2017 - 01/2009
3	Diabetes Complications 10/2017 - 12/2011
3	Thyroid Neoplasms (Thyroid Cancer) 01/2016 - 10/2014
3	Weight Gain 07/2015 - 01/2013
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2014 - 01/2009
2	Fibrosis (Cirrhosis) 12/2021 - 10/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021 - 10/2021
2	Depressive Disorder (Melancholia) 05/2018 - 07/2012
2	Disease Progression 02/2018 - 02/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2009
2	Albuminuria 10/2017 - 01/2009
2	Osteoporosis 07/2014 - 08/2010

Drug/Important Bio-Agent (IBA)

34	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2006
14	Insulin (Novolin)FDA Link 01/2022 - 06/2008
12	CalciumIBA 12/2019 - 07/2009
11	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 01/2009
9	LipidsIBA 01/2019 - 05/2011
7	Triglycerides (Triacylglycerol)IBA 12/2021 - 02/2011
7	CholesterolIBA 12/2021 - 06/2011
7	AdiponectinIBA 01/2021 - 06/2008
6	NAD (NADH)IBA 01/2022 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2011
6	C-Reactive ProteinIBA 01/2019 - 01/2006
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2014
5	Pharmaceutical PreparationsIBA 12/2016 - 06/2012
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 04/2016
4	Apolipoproteins E (ApoE)IBA 12/2021 - 01/2013
4	Thyroid HormonesIBA 01/2020 - 09/2013
4	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 08/2012
4	HDL CholesterolIBA 01/2019 - 11/2006
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018 - 10/2014
4	Peptides (Polypeptides)IBA 10/2017 - 02/2011
4	lobeglitazoneIBA 10/2017 - 01/2014
4	CreatinineIBA 05/2017 - 01/2009
3	Vitamin D FDA LinkGeneric 06/2022 - 01/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2021 - 01/2009
3	Messenger RNA (mRNA)IBA 12/2021 - 09/2012
3	Interleukin-6 (Interleukin 6)IBA 12/2021 - 08/2012
3	AdipokinesIBA 01/2021 - 07/2012
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2012
3	Rosuvastatin Calcium (Crestor)FDA Link 03/2019 - 11/2017
3	Lipoproteins (Lipoprotein)IBA 12/2016 - 09/2013
3	ApolipoproteinsIBA 03/2016 - 01/2013
3	C-PeptideIBA 12/2015 - 04/2011
3	HDL LipoproteinsIBA 06/2014 - 11/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 05/2010
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 06/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2021 - 01/2014
2	Apolipoprotein C-II (ApoC2)IBA 12/2021 - 01/2020
2	fibroblast growth factor 21IBA 11/2021 - 01/2019
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2020 - 06/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 01/2017
2	LigandsIBA 01/2019 - 11/2015
2	glimepiride (Amarel)FDA LinkGeneric 01/2019 - 01/2017
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2018 - 01/2014
2	LC15-0444IBA 01/2018 - 01/2017
2	Antihypertensive Agents (Antihypertensives)IBA 05/2017 - 01/2009
2	AlbuminsIBA 05/2017 - 01/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2017 - 05/2015
2	OsteocalcinIBA 12/2016 - 02/2016
2	N 30IBA 04/2016 - 10/2015
2	pitavastatin (itavastatin)FDA Link 03/2016 - 05/2015
2	AntibodiesIBA 01/2016 - 05/2009
2	bisphenol AIBA 07/2015 - 06/2014
2	voglibose (Basen)IBA 01/2015 - 01/2014
2	AntioxidantsIBA 01/2014 - 01/2011

Therapy/Procedure

17	Therapeutics 01/2022 - 06/2009
4	Glycemic Control 04/2016 - 12/2011
3	Drug Therapy (Chemotherapy) 01/2020 - 07/2008
2	Bariatric Surgery 01/2022 - 01/2022
2	Fitness Trackers 07/2018 - 02/2018
2	Aftercare (After-Treatment) 02/2018 - 05/2017
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2016 - 06/2009